Serum gamma glutamyl transferase levels in association with lipids and lipoproteins in type2 diabetes mellitus

Duggirala Rajarajeswari, T. Sharmila Krishna, M. Prasad Naidu, Jupalli Nagayya Naidu

Abstract


Background:Serum gamma glutamyl transferase is widely used as a marker for alcohol induced liver disease. Recently it has gained importance due to its role in type2 diabetes mellitus. A raised serum gamma glutamyl transferase level indicates hepatic steatosis and visceral fat deposition, leading to insulin resistance and diabetes. In the present study we examined the association between serum gamma glutamyl transferase levels with lipids and lipoproteins in diabetes mellitus.  

Methods:The study was carried out on 50 subjects with type 2 diabetes mellitus and compared with 50 age and sex matched healthy controls attending outpatient department of general medicine, Narayana medical college, Nellore. Serum gamma glutamyl transferase was measured by calorimetric kinetic assay. Fasting blood sugar was measured by glucose oxidase method using automated analyzer. Serum triglycerides, total cholesterol and high density lipoprotein are measured by standard enzymatic procedures and low density lipoprotein by Friedwald equation.

Results:Serum gamma glutamyl transferase levels in diabetic cases were significantly elevated compared to normal healthy controls (P <0.001). There was a positive correlation between gamma glutamyl transferase, lipids and low density lipoprotein and inverse correlation with high density lipoprotein (r = -0.298).  

Conclusion:Our results suggest a possible role of gamma glutamyl transferase in the pathophysiology and progression of type 2 diabetes mellitus.

 


Keywords


Serum gamma glutamyl transferase, lipids, Blood glucose, Type 2 diabetes mellitus

Full Text:

PDF

References


André P, Balkau B, Charles MA, Eschwège E. Gamma-glutamyl transferase activity and development of the metabolic syndrome, in middle-aged men and women: the DESIR cohort. Diabet Care. 2007;30(9):2355-61.

Whitfield JB. Gamma glutamyl transferase. Crit Rev Clin Lab Sci. 2000;138(4):263-355.

Benini F, Pigozzi MG, Baisini O, Romanini L, Ahmed H, Pozzi A, et al. Increased serum gamma‐glutamyl‐transpeptidase concentration is associated with non-alcoholic steatosis and not with cholestasis in patients with chronic hepatitis C. J Gastroenterol Hepatol. 2007;22(10):1621-26.

Huseby NE. Hydrophilic form of γ-glutamyl transferase: proteolytic formation in liver homogenates and its estimation in serum. Clin Chim Acta. 1982;124(1):113-21.

Grundy, Scott M. Gamma-glutamyl transferase another biomarker for metabolic syndrome and cardiovascular risk. Arterioscl Thromb Vasc Biol. 2007;27(1):4-7.

Sabanayagam C, Shankar A, Li J, Pollard, Ducatman A. Serum gamma-glutamyl transferase level and diabetes mellitus among US adults. Eur J Epidemiol. 2009;24(7):369-73.

Lim JS, Lee DH, Park JY, Jin, Jacobs. A strong interaction between serum γ-glutamyl transferase and obesity on the risk of prevalent type 2 diabetes: results from the third national health and nutrition examination survey. Clin Chem. 2007;53(6):1092-8.

Duckworth, William C, Frederick G. Hamel, Daniel E. Peavy. Hepatic metabolism of insulin. Am J Med. 1988;85.5:71-6.

Kasapoglu B, Turkay C, Bayram Y, Koca C. Role of GGT in diagnosis of metabolic syndrome: a clinic-based cross-sectional survey. Indian J Med Res. 2010;132(1):56-61.

Lippi G, Targher G, Montagnana M, Salvagno GL, Guidi GC. Relationship between gamma-glutamyl transferase, lipids and lipoprotein(a) in the general population. Clin Chim Acta. 2007;384:163-6.

Vozarova B, Stefen N, Lindsey RS, Saremi A, Pratley RE, Bogardus C, et al. High alanine aminotransferase is associated with decreased hepatic insulin sensitivity and predicts the development of type 2 diabetes. Diabetes. 2002;51:1889-95.

Vartiainen E, Jousilahti P, Alfthan G, Sundvall J, Pietinen P, Puska P. Cardiovascular risk factor changes in Finland 1972-1997. Int J Epidemiol. 200;29:49-56.

Koro CE, Bowlin SJ, Bourgeois N, Fedder DO. Glycemic control from 1988 to 2000 among US adults diagnosed with type 2 diabetes a preliminary report. Diabet Care. 2004;27(1):17-20.

Lee Duk-Hee, Myron D. Gross, David R. Jacobs. Association of serum carotenoids and tocopherols with γ-glutamyltransferase: the cardiovascular risk development in young adults (CARDIA) Study. Clin Chem. 2004;50.3:582-8.

Duk-Hee Lee, Rune Blomhoff, David R. Jacobs Jr. Is serum gamma glutamyl transferase a marker of oxidative stress? Free Radic Res. 2004;38.6:535-9.

Sabanayagam C, Shankar A, Li J, Pollard C, Ducatman A. Serum gamma-glutamyl transferase level and diabetes mellitus among US adults. Eur J Epidemiol. 2009;24:369-73.

Iqbal Azhar, Uzma Iftikhar, Farah Amir Ali, Shakoor Memon, Nudrat Zuberi. Comparison of gamma glutamyl transferase in normal and in type 2 diabetics. J Pak Med Assoc. 2010;60(11):945-8.

Giovanni Targher, Lorenz Bertolini, Felice Poli, Stefano Rodella, Luca Scala, Tessari R, et al. Non-alcoholic fatty liver disease and risk of future cardiovascular events among type 2 diabetic patients. Diabetes. 2005;54(12):3541-6.